Close

Analyst Ratings for NovaBay Pharmaceuticals (NBY) [Neutrals]

All Latest Ratings for NBY

NBY Rating Summary

NBY Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NBY
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $9.50 (+11775%) * Over Last 12-Mos
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/13/2019 Laidlaw
» Updated 7/29/2019		 Francois Brisebois Downgrade Hold
(Buy)		 1.00
(0.75)		 1.50
(0.08)		 -94.67% Details
3/13/2019 H.C. Wainwright Raghuram Selvaraju Downgrade Neutral
(Buy)		 1.25
(N/A)		 1.39
(0.08)		 -94.24% Details